Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

AbbVie's $8.7bn play for Cerevel looks like a poor bet as its lead schizophrenia drug flunks two phase 2 trials, but which rival stands to benefit?

Have you found all the Iron Galaxy logos in Tony Hawk's Pro Skater 3 + 4? Tell us in the comments section below, and check out our Tony Hawk's Pro Skater 3 + 4 guide for more.

Positive top-line results from the Phase III EMERGENT-4 and EMERGENT-5 open-label trials evaluating the long-term efficacy, safety, and tolerability of Cobenfy (xanomeline and trospium chloride) in ...

Drugs that target the GPCR family make up about 34 per cent of all US Food and Drug Administration (FDA) approved drugs including, for example, Cobenfy (for schizophrenia) and semaglutide (Ozempic, ...

Discover the fascinating evolution of the Burberry logo design history, from its 1901 origins to the modern minimalist design and brand identity.

We will look at the top 10 best 80s logos by design features, cultural significance and how far-reaching these accolades have been up to date.

Get the latest news and real-time alerts from Bristol-Myers Squibb Company (BMY) stock at Seeking Alpha.

During his tenure on the board, Dr. Kucherlapati helped guide PureTech from its startup phase into an established biotherapeutics company, which has an industry-leading track record of advancing ...

Major depressive disorder (MDD) is a common but serious mental health condition. Diagnosis is based on a thorough evaluation by a trained medical or mental health professional—such as a primary care ...